Member Info for Rudey

Over here or over there?

Strictlyinc, personally I prefer to build a position as the price rises. Each buy is protected by the potential profit from previous buys, plus I pay the brokers less commission. However, had I bought my current holding outright when I first started buying, my average would be around 7p. Instead it's 8.6. Which, in retrospect, would I rather have? If Swapleber's cash has only now become available, in a couple of weeks he may be very pleased he's not buying in 50 or 100k chunks.
Only time will tell I suppose.

Well done swaplebar. Trust in your research.

Exactly Northseatiger. He doesn't want to let them go.

I take it your post was aimed at moniman, not me gotabesirius. Surely he was joking?

My own personal view is that nothing with meat on the bone was announced in the Doc Holiday interview, so what Cathal said today doesn't need to be RNS'd. Mind you, it should kick a few dithering investors up the backside as to what the potential here really is.

Afternoon SAS. Sorry I missed your post - had lunch down the pub. Haha, I wish - been gardening.
All good thanks. I'm finished buying. Nice round number, makes working out profit easier! lol Fingers crossed, but looks very promising to me. I see your buy showed up. good luck.

A lot of buys of 100k plus are being delayed SAS.

Hasn't he invested half of his net worth in the company?

One is mine Trader_3 for what it's worth.

This is a pretty unique situation. There haven't been many times when you've got the only oil refinery in the world!

I would have thought that at the end of all this, there will be a lot of finger wagging at the Chinese. No doubt it would earn them a few brownie points if they were seen to be doing everything they can to try to find anti-virals and vaccines, not only in China but in places like LONDON where they're findings could be available for scrutiny and approval by western governments. Buying Open Orphan could therefore be politically beneficial, as well as saving thousands of lives? Or is this just wishful thinking?

Terrific summary Trader_3.

https://www.openorphan.com/covid-19

Open Orphan is a newly created niche CRO pharmaceutical services company which is the world leader in testing vaccines & antivirals through human challenge studies. Open Orphan is actively involved in the fight against COVID-19 and is developing the world’s first coronavirus challenge study model.
In June 2019 Open Orphan acquired AIM-listed Venn Life Sciences plc in a reverse take-over and in January 2020 completed a merger with hVIVO plc. hVIVO has Europe’s only 24-bedroom quarantine clinic with onsite virology lab and has recently commenced testing on a potential antiviral treatment for COVID-19.
Open Orphan (ORPH) is quoted on both the AIM and Euronext Growth market.
(From ShareSoc)

Of course that doesn't mean that's achievable, but there's also more to the company than hVIVO.

ir@openorphan.com

Spencer, I concur. I seem to remember CF saying that at the time that Open Orphan acquired hVIVO, it was worth many tens of the £13m paid. So that's a minimum of £260m if my maths are right - and that was before the pandemic.

Great week just finished. I'm looking forward to next week too. Onwards and upwards.

Glad I'm not out for the weekend!

Strictly, I was in GKP about 5 years ago. Lost £1,800 if I remember correctly. Afren was by big loser - took a couple of years to get my losses back.